Ningyan Zhang

USPTO Granted Patents = 20 (Patent Applications = 20)

CIPO Patents = 4 (Patent Applications = 10)

EPO Patents = 4 (Patent Applications = 19)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

West Point, PA (US) (2016)
Ambler, PA (US) (2016)
Pearland, TX (US) (2020 - 2022)
Houston, TX (US) (2017 - 2024)
Dallas, TX (US) (2023 - 2024)

Company Filing History:

17 out of 5,444

University of Texas System

patents

4 out of 2,405

Merck Sharp + Dohme Corp.

patents

2 out of 8

Acumen Pharmaceuticals, Inc.

patents

4. 1 out of 1

Immune-onc Therapeutics, Inc.

patent

5. 1 out of 1,579

Washington University

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331130 - DDR1 antibodies and uses thereof (2025-06-17),

2. 12331110 - Monoclonal antibodies against endotrophin and the use thereof (2025-06-17),

3. 12202895 - LILRB4 antibodies and uses thereof (2025-01-21),

4. 12152071 - EGFL6 specific monoclonal antibodies and methods of their use (2024-11-26),

5. 12037390 - Leptin antibodies and method of reducing leptin (2024-07-16),

6. 11912758 - Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel (2024-02-27),

7. 11906519 - Methods for identifying LILRB-blocking antibodies (2024-02-20),

8. 11760799 - Leptin antibodies (2023-09-19),

9. 11498963 - Anti-LILRB antibodies and their use in detecting and treating cancer (2022-11-15),

10. 11377491 - Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer (2022-07-05),

11. 11230591 - CMV neutralizing antigen binding proteins (2022-01-25),

12. 11174320 - HER3 specific monoclonal antibodies for diagnostic and therapeutic use (2021-11-16),

13. 10889637 - Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies (2021-01-12),

14. 10875912 - EGFL6 specific monoclonal antibodies and methods of their use (2020-12-29),

15. 10501538 - Anti-LILRB antibodies and their use in detecting and treating cancer (2019-12-10),

Title: The Innovative Journey of Inventor Ningyan Zhang

Introduction: Ningyan Zhang, a talented inventor based in Houston, TX, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Ningyan Zhang holds several patents in the areas of artificial intelligence, renewable energy, and advanced materials. His most recent patent involves a cutting-edge algorithm for optimizing solar panel efficiency.

Career Highlights: With a background in engineering and computer science, Ningyan Zhang has worked for leading tech companies where he honed his skills in research and development. His passion for creating solutions to complex problems has driven him to push the boundaries of innovation.

Collaborations: Throughout his career, Ningyan Zhang has collaborated with top researchers and scientists in multidisciplinary projects. His ability to work in diverse teams has led to the successful development of pioneering technologies.

Conclusion: Ningyan Zhang's relentless pursuit of innovation and his commitment to excellence continue to inspire the next generation of inventors. His impact on the tech industry is profound, and his legacy will undoubtedly shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.